Health Care

— Nov 8, 2018
Printer-friendly version

Comparing Performance of Universal Health Care Countries, 2018 finds that Canada spends more on health care than a majority of 28 comparable countries with universal coverage, but ranks near the bottom in terms of the number of physicians and hospital beds, and Canada suffers from the longest wait times.

— Oct 16, 2018
Printer-friendly version
Provincial Drug Coverage for Vulnerable Canadians

Provincial Drug Coverage for Vulnerable Canadians finds that every province already provides prescription drug coverage to help Canadians—particularly seniors and lower-income Canadians—pay for pharmaceuticals. Crucially, provinces are able to establish prescription drug plans to suit their particular priorities, population age, income levels and other factors, which differ from province to province. This customization would likely be lost or at least diluted if Canada adopts a national pharmacare program.

— Aug 28, 2018
Printer-friendly version
Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada

Regulatory, Reimbursement and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada finds that the federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians suffering from cystic fibrosis and other rare diseases may soon lose access to new innovative drug treatments, even though these patients are already denied new drugs available elsewhere.

— Jul 31, 2018
Printer-friendly version
The Price of Public Health Care Insurance, 2018

The Price of Public Health Care Insurance, 2018 finds that a typical Canadian family of four will pay $12,935 for health care in 2018. After adjusting for inflation, that’s an increase of 68.5 per cent since 1997, the first year estimates could be calculated. For single Canadians, health-care costs have more than doubled over that same time period—from $2,115 (in 2018 dollars) to $4,640 this year.

— Jul 20, 2018
Printer-friendly version
Implications of the proposed changes to Canada's pharmaceutical pricing regulations

Implications of the Proposed Changes to Canada’s Pharmaceutical Pricing Regulations finds that the federal government’s plan to lower the cost of patented pharmaceuticals in Canada through new regulations seriously risks limiting patient access to new innovative drugs. The is the first study in a series on pharmaceutical drug pricing policy reforms.

— May 23, 2018
Printer-friendly version
The Private Cost of Public Queues for Medically Necessary Care, 2018

The Private Cost of Public Queues for Medically Necessary Care, 2018 finds that Canada’s long wait times for medically necessary treatments cost Canadians $1.9 billion—or $1,822 per patient—in lost wages and time last year. Including the value of lost time outside the traditional work week—evenings and weekends—the estimated cost of waiting jumps to $5.8 billion.

— May 1, 2018
Printer-friendly version
Is the Canada Health Act a Barrier to Reform?

Is the Canada Health Act a Barrier to Reform? finds that the provinces are discouraged from implementing proven health-care reforms that would improve the system and shorten wait times because of the Canada Health Act, which not only sets the rules around cash transfers from Ottawa to the provinces for health care, but also allows the federal government to withhold funds from any province deemed in violation of the Act.

Research Experts